Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Chinese, Canadian Researchers ID Anti-Bird Flu Compound

This article was originally published in PharmAsia News

Executive Summary

Hong Kong and Canadian scientists working on a genome technology report found a compound that inhibits the H5N1 bird flu virus. The team said it tested 20 compounds and found one it labeled "compound-1" that inhibits neuraminidase involved in viral replication. The compound was found to operate at a level similar to oseltamivir, the active ingredient in Roche's Tamiflu, known to be losing its effectiveness against the virus. The identified compound was able to bind to the neuraminidase of the virus and, according to the researchers, might overcome the drug resistance. (Click here for more

Latest Headlines
See All
UsernamePublicRestriction

Register

SC071349

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel